Press release
Neuroleptic Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030
A full report of Neuroleptic Market is available at: https://www.omrglobal.com/industry-reports/neuroleptic-market
The rising incidence of psychiatric disorders places a significant pressure on healthcare system. As a result, the government is focused on raising awareness about disorders and the efficacy of drugs used to treat them. As a result, there is a huge demand for highly effective and safe drugs to treat people with psychotic disorders all over the globe. Furthermore, the firms are concentrating on the identification of innovative antipsychotic injectable drugs that reduce the need to monitor the patient's drug consumption. Schizophrenia and psychotic disorders have a high incidence, which is driving the global antipsychotic drug market. Additional reasons driving the market growth for antipsychotic drugs include increased drug abuse, over-prescription of drugs, and addiction to antipsychotic drugs.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/neuroleptic-market
In March 2020, Dr. Reddy's Laboratories announced the launch of Ziprasidone Mesylate for injection, 20 mg (base)/ml single-dose vials, in the United States. Ziprasidone Mesylate for injection is the generic therapeutic equivalent to Pfizer's Geodon injection.
In January 2020, The US Food and Medication Administration (FDA) had approved Alkermes' experimental antipsychotic drug candidate ALKS 3831 (olanzapine/samidorphan), which is used to treat schizophrenia and bipolar I disorder.
Market Coverage
The market number available for - 2020-2027
Base year- 2020
Forecast period- 2021-2027
Segment covered
o By Type
o By Application
o By distribution
Competitive Landscape- Eli Lily and Company., AstraZeneca., GlaxoSmithKline plc., Johnson & Johnson., Otsuka Pharmaceutical Co, Ltd., and Pfizer Inc., among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominates the market in base year?
Which segment and region will project fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Market Segmentation
By Type
Risperidone
Olanzapine
Quetiapine
Ziprasidone
Aripiprazole
Paliperidone
Lurasidone
By Application
Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Major Depressive Disorder (MDD)
By Distribution
Hospital Pharmacy
Retail Pharmacy
Drug Store
E-commerce
Neuroleptic Market- Segment by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
Company Profiles
Eli Lily and Company.
GlaxoSmithKline plc.
Johnson & Johnson.
Otsuka Pharmaceutical Co, Ltd.
Pfizer Inc.
Reasons to Buying From us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroleptic Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030 here
News-ID: 3158711 • Views: …
More Releases from Orion Market Research
Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Lead …
The Global Digital Innovation in Insurance Market is projected to reach around USD 250 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 9.5% from 2024 to 2033.
Digital Innovation in Insurance Market Overview
The Digital Innovation in Insurance Market encompasses the integration of advanced technologies such as Artificial Intelligence (AI), Blockchain, the Internet of Things (IoT), and Big Data analytics into the insurance sector. These innovations are…
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
The Global Cigarette Rolling Paper Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 41.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 34.5% from 2024 to 2033.
Cigarette Rolling Paper Market Overview
The Global Cigarette Rolling Paper Market has experienced significant growth, driven by increasing consumer preference for hand-rolled cigarettes, particularly among younger and budget-conscious smokers. These papers…
Back Glue Market: Emerging Trends and Growth Forecast to 2033
The Global Back Glue Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.1% from 2024 to 2033.
Back Glue Market Overview
The Global Back Glue Market encompasses adhesives designed for various applications, including bookbinding, phone back panels, and other industrial uses. Advancements in technology have led to the development of high-performance back glue adhesives, which are anticipated to drive…
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
The Global Autopilot Systems Market was valued at approximately USD 5.8 billion in 2023 and is projected to reach around USD 10.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.4% from 2024 to 2033.
Autopilot Systems Market Overview
The Global Autopilot Systems Market encompasses advanced flight control systems designed to automate the navigation and operation of aircraft, reducing the need for manual input by pilots. These…
More Releases for Neuroleptic
Neuroleptic Market Increasing Demand, Growth Analysis and Future Outlook by 2030
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the…
Neuroleptic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Neuroleptic Drugs Market Overview:
Neuroleptic Drugs Market Witnesses Steady Growth with Anticipated CAGR of 5.6%
The global neuroleptic drugs market is poised to witness substantial growth, projecting a Compound Annual Growth Rate (CAGR) of 5.6% throughout the forecast period spanning from 2022 to 2029.
Antipsychotics, also recognized as neuroleptics, continue to be at the forefront of psychiatric treatment, notably combating schizophrenia and a spectrum of other psychotic disorders.
Market Metrics
CAGR: 5.6%
Segments Covered: By…
Neuroleptic Market Outlook 2029: Presents Market Insights & Depth Analysis
This Neuroleptic Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Neuroleptic Market study report. All this crucial data…
Neuroleptic Market Share 2023: Global Trends, Key Players, Industry Analysis and …
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the…
Neuroleptic Market Share 2021: Global Trends, Key Players, Industry Analysis and …
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the…
Neuroleptic Market Analysis and Growth to 2025: by Key Companies Johnson & Johns …
The research study offers powerful guidelines for market players to compete well against other participants operating in the global Neuroleptic market. It brings to light crucial market dynamics including drivers, challenges, restraints, trends, and opportunities. Readers are provided with detailed qualitative and quantitative analysis, PESTLE analysis, absolute dollar opportunity analysis, and Porter’s Five Forces analysis that focus on various aspects of the global Neuroleptic Market. The report includes regional growth…
